Bayer Schering Pharma

Bayer Schering Pharma is a division of Bayer HealthCare, and is the biggest division in China with 2000 employees. Bayer Schering Pharma has run its business in more than 70 key cities across China, developing, producing and selling high-tech patent drugs in different fields, including cardiovascular disease, infection, endocrinology, urinary system, oncology, gynecology and diagnostic imaging. Visit www.bayer.com.

Oracle Health Sciences

Oracle is a leading strategic software solutions provider to the health sciences industry. Oracle Health Sciences helps pharmaceutical, biotechnology, medical device, and healthcare organizations become the most successful in the world by offering the most innovative products and services that deliver the most compelling customer and shareholder value. Addressing industry requirements, Oracle provides comprehensive solutions including clinical trial management and analysis, electronic data capture, adverse event reporting and pharmacovigilance, and healthcare interoperability. Oracle partners with health sciences industry leaders – including 20 of the top 20 life sciences companies and 10 of the top 12 Fortune Global 500 healthcare organizations – to prevent and cure disease and enhance quality of life.

Pfizer

Pfizer has been operating in China since the early 1980's committed to improving the health of the Chinese people and contributing to China's overall prosperity. Pfizer has built on this legacy by introducing innovative, relevant medicines and investing in doctor and patient educational programs. Furthermore, Pfizer contributes to China's scientific and medical development by including China in our global R&D projects. In recognition of the highly-skilled and talented scientists in China, Pfizer established its China Research and Development Center in Shanghai in 2005. The center is staffed with more than 200 Pfizer colleagues supporting various aspects of Pfizer's global R&D efforts.

Paramax International Inc.

Paramax International Inc. (www.paramaxinternational.com) is a premier CRO in the U.S. and China providing professional services to biopharma and medical device companies worldwide. We have a strong presence with wide geographic coverage in China. Our services in China include clinical monitoring, project management, medical writing, regulatory affairs, data management and biostatistics, etc.. At Paramax, we always commit to quality, deliver our promise, pursue service excellence and continuously improve our performance.

PAREXEL International Corporation

PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 63 locations throughout 52 countries around the world, and has more than 8,050 employees. For more information about PAREXEL International visit www.PAREXEL.com.

PPD

PPD is a leading global contract research organization providing discovery, development and post-approval services to our clients in pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 31 countries, including 11 locations throughout Asia Pacific, and more than 10,400 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients maximize returns on their R & D investments. Our capabilities extend beyond our office locations to the broader Asia Pacific region. PPD provides a full range of highly customized global central lab services in China through an exclusive agreement with Peking Union Lawke Biomedical Development Limited (PUL).

Quintiles Asia Pacific

Quintiles is the global leader in pharmaceutical services, improving healthcare worldwide by providing innovative, quality professional expertise, market intelligence and partnering solutions to meet the dynamic needs of the pharmaceutical, biotechnology and healthcare industries. Quintiles Asia Pacific has clinical development offices in 13 countries. Since 1993, the Quintiles clinical team in Asia Pacific has completed over 600 clinical trials involving about 3,500 sites and more than 80,000 patients. It offers the full spectrum of clinical development services, including clinical research, laboratory services, regulatory affairs and consulting to pharmaceutical and biotechnology firms. In short, Quintiles has the resources and the right approach to deliver excellent results for small and large projects every step of the way, in Asia and virtually anywhere in the world, bringing true value to clinical development investments.

BioBay

BioBay is located in Dushu Lake Higher Education Town of Suzhou Industrial Park. BioBay is building total 1 million square meter facility with 36% green ratio on the land of 86.3 hectares. Under visionary and professional planning and construction monitoring by world-class architectural and pharmaceutical industry design firm, BioBay has built 70,000 m2 of incubation buildings and 24,000 m2 total of four individual R&D buildings, another 160,000 m2 area of facilities will be completed by end of 2008 catering for research and development, pilot-manufacturing, nanotech commercialization, commercial and living amenities. BioBay has more than 80 high-tech companies focusing on biotech, pharmaceutical, diagnostics, medical device, CRO, nanotech, and is committed to building a dynamic and interactive innovation cluster for talents and experts. BioBay has been officially designated as China International Nano-tech Innovation Cluster by Ministry of Science & Technology of PRC, Ministry of Commerce of PRC, and as Jiangsu Province Biopharmaceutical Incubator as well.

Covance Inc.

Covance Inc.- one of the world's largest and most comprehensive drug development services companies - has the people, global resources and problem-solving culture to respond to pharmaceutical and biotechnology clients' toughest drug development challenges. We provide a portfolio of preclinical and clinical development and commercial service offerings - delivered through industry-leading nonclinical testing services, the world's largest central laboratory network, and a global team of clinical trial professionals and cardiac safety experts. With headquarters in Princeton, New Jersey, Covance Inc (NYSE: CVD) has annual revenues greater than $1.5 billion, global operations in 20 countries, and approximately 8,900 employees worldwide. Strategic partnerships built on decades of success - Covance is dedicated to helping bring your miracles to market sooner.

Excel PharmaStudies Inc.

Excel PharmaStudies Inc. is a full service provider of clinical research, registration, biometrics, and training and consultation services. Founded in Beijing in 1999, Excel has grown quickly to become the leading CRO in China. Working with more than 120 of the industry’s top global companies, Excel has conducted over 160 clinical trials (phase I~IV) and obtained over 200 regulatory approvals. Additionally, Excel’s 13 offices, located strategically throughout China, allow access to a broad range of subjects. Through this far-reaching network, Excel has managed sites in over 40 cities, worked with over 150 hospitals, and enrolled over 150,000 subjects.

Fountain Medical Development

Fountain Medical Development Ltd. is a contract research organization (CRO) offering a full range of ICH GCP compliant clinical research services for multinational clients conducting clinical research in China. We fill the void of a service provider that balances high quality with moderate cost. Our extensive global experience in multiple therapeutic areas is unmatched by other local CRO's, and our lower operational cost allows us to pass significant savings on to our clients.

Beijing WBL Peking University Biotech Co., Ltd. (WPU)

Beijing WBL Peking University Biotech Co., Ltd. (WPU), is a high-tech pharmaceutical joint-venture of Peking University, the Asiapharm Group Ltd of Singapore and the Beijing Enterprises Holdings Limited of Hong Kong, which was founded in 1994 with registered capital of RMB 80 million. It mainly engages in the research, development, production and marketing of natural drugs and modern Chinese medicine. Xuezhikang capsule (XZK), the lipid-regulating Chinese medicine, is a leading product of WPU. It is an extract from Red Yeast Rice (Hong Qu) and is highly effective in reducing body’s TC, TG, and LDL-C atherosclerosis index (AI) and elevating HDL-C level. A randomized placebo-controlled trial, the Chinese Coronary Secondary Prevention Study (CCSPS), published in June 15 issue of the American Journal of Cardiology shows that, the long-term therapy with XZK significantly decreased the recurrence of coronary events. The IND application of XZK in US has been approved in September 2008. For more information, visit www.wpu.com.cn/english

Aperio

Aperio provides systems and services for digital pathology. Our award-winning ScanScope® slide scanners, automated image analysis, and Spectrum™ digital pathology information management software, including a tissue microarray (TMA) segmentation tool and reporting, improve the efficiency and quality of pathology services for pathologists and other professionals. For more information, visit www.aperio.com

Medidata Solutions

Medidata Solutions (www.mdsol.com) is a leading provider of clinical trial solutions that enable the world's most advanced life science organizations to maximize the value of their clinical research investments. A pioneer since 1999 in innovative technologies to optimize clinical research processes - protocol design; clinical data capture, management and reporting; and trial planning and negotiation - Medidata Solutions helps clinical researchers reduce trial cycle times, achieve early visibility to reliable clinical data, and maintain strict fiscal responsibility, while safely accelerating the process of bringing life-enhancing treatments to market.

Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm™), phase I clinic automation (LabPas™), clinical data management (Clintrial™), clinical trials signal detection (CTSD™), strategic pharmacovigilance (Empirica SignalTM) and Signal Management, adverse event reporting (Empirica Trace™), applied data standards (WebSDM™) and Web-integrated interactive response technology (Clarix™). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Additional information about Phase Forward is available at www.phaseforward.com.

TransPerfect Translations

TransPerfect is the world’s leading provider of multilingual communications services to life sciences organizations. We offer an ISO 9001:2000-certified quality management system, rigorously-tested medical linguists, and 24/7 production capabilities in over 50 locations globally. This certified quality assurance process enables us to provide expert translation services in over 100 languages and meet the most demanding deadlines. Each translation is created by a team of professional translators, editors, and proofreaders who are selected for their target expertise and native-speaking skills only after they pass our rigorous testing process. Not only do our technology products reduce costs and improve consistency, but we now offer an on-line collaboration platform known as "Trial Interactive"™. This platform is an easy-to-use portal that manages the submission, tracking and organization of global clinical study documentation in a highly secure environment and is available in 20 languages.

TransPerfect: The ideal choice for clinical research, pharmaceutical, and biotechnology companies.

Zuellig Pharma

Zuellig Pharma is a leading logistics and distribution provider of multinational pharmaceuticals in Asia for over 60 years. Since established in 1993, Zuellig Pharma China has been able to build a formidable reputation for the highest standards in modern pharmaceutical logistics & distribution services. We offer an unparalleled range of clinical trial logistics services, full transparency on supply chain visibility that cover the entire project life of study protocol through an extensive distribution network operations in China and innovative information platform. Our distribution network covers all provinces, over 400 cities, 450 CDC, 37,000 hospitals. With drug depots located both in Shanghai and Beijing, Zuellig Pharma currently provide the full range of clinical trials logistics solution ranging from importation, customs clearance, CTA and related regulatory assistance, investigation drug storage and inventory management, re-labeling, drug distribution as well as supplies return and destruction. Visit www.zuelligpharma.com.

The Association of Clinical Research Organizations (ACRO)

The Association of Clinical Research Organizations (ACRO) is the professional organization of companies whose focus is clinical research. The association provides an active voice for the clinical research organization (CRO) industry, which provides specialized services that are integral to the development of drugs, biologics and medical devices. ACRO helps its members improve the quality, efficiency and safety of biomedical research. For more information, please visit www.acrohealth.org.

Chinese Biopharmaceutical Association – USA

Headquartered in Maryland, the Chinese Biopharmaceutical Association – USA (CBA) is one of the largest Chinese American professional associations in the US. Founded in 1995, CBA is an independent, non-political, not-for-profit professional organization led by its volunteer-based board of directors and executive management team. CBA’s mission is to promote career advancement of and collaborations among Chinese American biopharmaceutical professionals, and to promote technology transfer and business collaboration among different countries and regions, especially between the United States and China. On May 28-30, 2008, CBA co-hosted its 13th Annual Conference with Shanghai Bio-Forum in Shanghai. Participated in by nearly 1000 attendees from all over the world, the conference was a huge success. For more information, please visit www.cba-usa.org.

ChinaBio® Accelerator

ChinaBio® Accelerator is a non-profit organization created to accelerate the globalization of China's biotechnology industry by providing funding, mentoring and connecting early stage China life science companies to investors and partners in the U.S. If you are an early stage China biotech seeking funding or U.S. partnerships, or a U.S.-based organization looking to establish partnerships or operations in China, please contact us to find out how we can help. www.ChinaBioLLC.com.

Sino-American Pharmaceutical Professionals Association (SAPA)

Founded in 1993, the Sino-American Pharmaceutical Professionals Association (SAPA) grew rapidly and has become one of the most active and well-recognized Chinese-heritage enduring professional organizations in the United States. SAPA is an independent, nonprofit and professional organization with over 4,000 members. Its headquarters is based in the tri-state area (NY-NJ-CT) with three regional chapters in New England, Greater Philadelphia and California, and one club in Shanghai, China. Visit www.sapaweb.org.